[go: up one dir, main page]

FI853004L - Nya renin inhiberande polypeptidanaloger och foerfaranden foer framstaellning av dem. - Google Patents

Nya renin inhiberande polypeptidanaloger och foerfaranden foer framstaellning av dem.

Info

Publication number
FI853004L
FI853004L FI853004A FI853004A FI853004L FI 853004 L FI853004 L FI 853004L FI 853004 A FI853004 A FI 853004A FI 853004 A FI853004 A FI 853004A FI 853004 L FI853004 L FI 853004L
Authority
FI
Finland
Prior art keywords
polypeptidanaloger
inhiberande
nya
renin
dem
Prior art date
Application number
FI853004A
Other languages
English (en)
Other versions
FI88400C (fi
FI853004A0 (fi
FI88400B (fi
Inventor
Jackson Boiling Hester Jr
Donald Theodore Pals
Hossain Hassain Saneii
Tomi Kim Sawyer
Heinrich Josef Schostarez
Ruth Elizabeth Tenbrink
Suvit Thaisrivongs
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Priority to FI912228A priority Critical patent/FI912228A0/fi
Publication of FI853004A0 publication Critical patent/FI853004A0/fi
Publication of FI853004L publication Critical patent/FI853004L/fi
Application granted granted Critical
Publication of FI88400B publication Critical patent/FI88400B/fi
Publication of FI88400C publication Critical patent/FI88400C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0227—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96472—Aspartic endopeptidases (3.4.23)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Furan Compounds (AREA)
FI853004A 1984-08-06 1985-08-05 Foerfarande foer framstaellning av renin inhiberande peptider FI88400C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI912228A FI912228A0 (fi) 1984-08-06 1985-08-05 Nya renin inhiberande polypeptidanaloger och foerfaranden foer framstaellning av dem.

Applications Claiming Priority (18)

Application Number Priority Date Filing Date Title
US63804184A 1984-08-06 1984-08-06
US63802784A 1984-08-06 1984-08-06
US63802584A 1984-08-06 1984-08-06
US63802384A 1984-08-06 1984-08-06
US63802784 1984-08-06
US63802384 1984-08-06
US63802584 1984-08-06
US63804184 1984-08-06
US66302684A 1984-10-19 1984-10-19
US66309384A 1984-10-19 1984-10-19
US66302884A 1984-10-19 1984-10-19
US66302784A 1984-10-19 1984-10-19
US66309384 1984-10-19
US66302684 1984-10-19
US66302784 1984-10-19
US66302884 1984-10-19
US75319885A 1985-07-09 1985-07-09
US75319885 1985-07-09

Publications (4)

Publication Number Publication Date
FI853004A0 FI853004A0 (fi) 1985-08-05
FI853004L true FI853004L (fi) 1986-02-07
FI88400B FI88400B (fi) 1993-01-29
FI88400C FI88400C (fi) 1993-05-10

Family

ID=27578888

Family Applications (1)

Application Number Title Priority Date Filing Date
FI853004A FI88400C (fi) 1984-08-06 1985-08-05 Foerfarande foer framstaellning av renin inhiberande peptider

Country Status (4)

Country Link
EP (2) EP0486478A3 (fi)
JP (2) JPH05222063A (fi)
DK (1) DK356085A (fi)
FI (1) FI88400C (fi)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613676A (en) * 1983-11-23 1986-09-23 Ciba-Geigy Corporation Substituted 5-amino-4-hydroxyvaleryl derivatives
JPS60163899A (ja) * 1984-02-03 1985-08-26 Sankyo Co Ltd レニン阻害ペプチド類
EP0181110A3 (en) * 1984-10-22 1988-05-11 Kissei Pharmaceutical Co. Ltd. Histidine derivatives as renin inhibitors
US4727060A (en) * 1984-11-13 1988-02-23 Ciba-Geigy Corporation Novel 5-amino-4-hydroxyvaleryl derivatives
EP0190891A3 (en) * 1985-01-31 1988-04-20 Kissei Pharmaceutical Co. Ltd. Novel amino acid derivatives
FI865196L (fi) 1985-04-19 1986-12-18 Upjohn Co Halostatinsubstituerade renin-inhibitorer.
US4882420A (en) * 1985-04-19 1989-11-21 The Upjohn Company Dihalo-statine substituted renin inhibitors
EP0206807A3 (en) * 1985-06-28 1988-01-20 Kissei Pharmaceutical Co. Ltd. Novel amino acid derivatives
CA1290097C (en) * 1985-07-24 1991-10-01 Merck & Co., Inc. Peptide enzyme inhibitors
US4729985A (en) * 1985-08-09 1988-03-08 Pfizer Inc. Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues
US4853463A (en) * 1985-09-04 1989-08-01 Kissei Pharmaceutical Co., Ltd. Amino acid derivatives
EP0245361A1 (en) * 1985-11-15 1987-11-19 The Upjohn Company Novel renin inhibiting polypeptide analogs containing s-aryl-d- or l- or dl-cysteinyl, 3-(arylthio)lactic acid or 3-(arylthio)alkyl moieties
US4894437A (en) * 1985-11-15 1990-01-16 The Upjohn Company Novel renin inhibiting polypeptide analogs containing S-aryl-D- or L- or DL-cysteinyl, 3-(arylthio)lactic acid or 3-(arylthio)alkyl moieties
NZ218937A (en) * 1986-01-16 1990-03-27 Abbott Lab Functionalised peptidyl aminodiols and -triols as renin inhibitors and pharmaceutical compositions
FI870474A7 (fi) * 1986-02-07 1987-08-08 Ciba Geigy Ag Med svavelhaltiga grupper substituerade 5-amino-4-hydroxivalerylderivat.
CA1309555C (en) * 1986-02-27 1992-10-27 Suvit Thaisrivongs Inhibiting peptides having a dihydroxyethylene isostere transitionstate insert
US4705846A (en) * 1986-03-27 1987-11-10 The Upjohn Company Novel renin inhibiting peptides having a gamma lactam pseudo dipeptide insert
DE3610593A1 (de) * 1986-03-29 1987-10-01 Hoechst Ag Substituierte 4-amino-3-hydroxybuttersaeure-derivate verfahren zu deren herstellung, diese enthaltende mittel und ihre verwendung
ES2066755T3 (es) * 1986-06-10 1995-03-16 Merck Patent Gmbh Derivados de aminoacidos inhibidores de renina.
JPS6322081A (ja) * 1986-07-11 1988-01-29 Kissei Pharmaceut Co Ltd 新規なアミノ酸誘導体
DE3627877A1 (de) * 1986-07-30 1988-02-04 Hoechst Ag Renin-hemmende di- und tripeptide, verfahren zu deren herstellung, diese enthaltende mittel und ihre verwendung
GB8619182D0 (en) * 1986-08-06 1986-09-17 Sandoz Ltd Peptides & derivatives
ES2053582T3 (es) * 1986-08-13 1994-08-01 Ciba Geigy Ag Procedimiento para la obtencion de derivados del acido 5-amino-4-hidroxivalerianico.
WO1988002374A2 (en) * 1986-09-30 1988-04-07 The Upjohn Company Renin inhibitory peptides having novel c-terminal moieties
EP0264106B1 (en) * 1986-10-14 1994-03-16 Banyu Pharmaceutical Co., Ltd. 5-Substituted amino-4-hydroxy-pentanoic acid derivatives and their use
EP0278158A3 (en) * 1986-11-12 1990-05-23 Merck & Co. Inc. Renin inhibitors containing phenylalanyl-histidine replacements
US4743585A (en) * 1986-11-21 1988-05-10 Warner-Lambert Company Renin inhibitors
US4895834A (en) * 1986-12-15 1990-01-23 Warner-Lambert Company Renin inhibitors III
JPH02501140A (ja) * 1986-12-22 1990-04-19 ジ・アップジョン・カンパニー エポキシドまたはグリコール基を有するレニン‐抑制ペプチド
SE8605573D0 (sv) * 1986-12-29 1986-12-29 Haessle Ab Novel compounds
US5032577A (en) * 1986-12-31 1991-07-16 Abbott Laboratories Peptidylaminodiols
GB2200115B (en) * 1987-01-21 1990-11-14 Sandoz Ltd Novel peptide derivatives, their production and use
US4758584A (en) * 1987-02-05 1988-07-19 Ciba-Geigy Corporation Antihypertensive 5-amino-4-hydroxyvaleryl derivatives substituted by sulphur-containing groups
AU1429788A (en) * 1987-03-09 1988-10-10 Upjohn Company, The Renin inhibitors containing a cyclopropyl amino acid and/or a cycloalkyl transition-state analogue
JPH02504509A (ja) * 1987-08-07 1990-12-20 ジ・アップジョン・カンパニー 非ペプチド結合を有するレニン抑制ペプチド
EP0395664A1 (en) * 1987-10-21 1990-11-07 The Upjohn Company Renin inhibitors containing a (1-amino-2-hydroxy-2-heterocyclic) ethyl moiety
GB8728560D0 (en) * 1987-12-07 1988-01-13 Glaxo Group Ltd Chemical compounds
GB8728561D0 (en) * 1987-12-07 1988-01-13 Glaxo Group Ltd Chemical compounds
ES2058489T3 (es) * 1988-01-26 1994-11-01 Sankyo Co Oligopeptidos con actividades inhibidoras de la renina, su preparacion y su uso.
WO1989007109A1 (en) * 1988-02-01 1989-08-10 The Upjohn Company Renin inhibiting peptides with polar end groups
US4981843A (en) * 1988-04-07 1991-01-01 E. R. Squibb & Sons, Inc. N-heterocyclic alcohol derivatives
AU3570089A (en) * 1988-05-03 1989-11-29 Upjohn Company, The Renin inhibitory peptides containing a substituted phenoxyacetyle group
DE3815913A1 (de) * 1988-05-10 1989-11-23 Sandoz Ag Neue reninhemmer, verfahren zu deren herstellung und deren verwendung
EP0347987A3 (en) * 1988-06-20 1991-01-02 Merck & Co. Inc. Tripeptide renin inhibitors with n-terminal carbamoyl or acyl groups
EP0423170A1 (en) * 1988-06-30 1991-04-24 The Upjohn Company Dipeptide hydroxy ethylene isostere synthesis and intermediates therefor
US5175298A (en) * 1988-06-30 1992-12-29 The Upjohn Company Dipeptide hydroxy ethylene isostere synthesis and intermediates therefor
EP0449943A1 (en) * 1988-12-22 1991-10-09 The Upjohn Company Transdermal and intranasal administration of renin inhibitory peptides
WO1990006914A1 (en) * 1988-12-22 1990-06-28 The Upjohn Company N-alkylation of n-alpha-boc-protected amino acids
US5342981A (en) * 1991-03-06 1994-08-30 Abbott Laboratories Substantially isomerically pure hexane or hexene compounds
US5229518A (en) * 1991-03-06 1993-07-20 Abbott Laboratories Isomerically pure 2-piperidone compounds
US5643878A (en) * 1991-09-12 1997-07-01 Ciba-Geigy Corporation 5-amino-4-hydroxyhexanoic acid derivatives
US5413999A (en) * 1991-11-08 1995-05-09 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
TW217410B (fi) * 1992-04-01 1993-12-11 Ciba Geigy
US5559256A (en) * 1992-07-20 1996-09-24 E. R. Squibb & Sons, Inc. Aminediol protease inhibitors
JP3409439B2 (ja) * 1994-06-17 2003-05-26 日産自動車株式会社 左右輪と前後輪の駆動力配分総合制御装置
US6486193B2 (en) 1998-12-31 2002-11-26 Aventis Pharmaceuticals Inc. 3-substituted pyrrolidines useful as inhibitors of matrix metalloproteinases
UA108742C2 (uk) 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO812612L (no) * 1980-08-06 1982-02-08 Ferring Pharma Ltd Enzym-inhibitorer.
CA1258748A (en) * 1981-10-08 1989-08-22 Daniel F. Veber Renin inhibitory peptides
JPS5865260A (ja) * 1981-10-13 1983-04-18 Microbial Chem Res Found ３−アミノ−２−ヒドロキシ−４−フエニル酪酸誘導体および医薬組成物
EP0104041B1 (en) * 1982-09-15 1988-07-27 Aktiebolaget Hässle Enzyme inhibitors
FI843837L (fi) * 1983-02-07 1984-09-28 Ferring Ab Enzyminhibitorer.
EP0144290A3 (de) * 1983-12-01 1987-05-27 Ciba-Geigy Ag Substituierte Aethylendiaminderivate
US4727060A (en) * 1984-11-13 1988-02-23 Ciba-Geigy Corporation Novel 5-amino-4-hydroxyvaleryl derivatives
FI865196L (fi) * 1985-04-19 1986-12-18 Upjohn Co Halostatinsubstituerade renin-inhibitorer.

Also Published As

Publication number Publication date
EP0173481A2 (en) 1986-03-05
EP0173481A3 (en) 1988-12-21
JPH05222063A (ja) 1993-08-31
FI88400C (fi) 1993-05-10
FI853004A0 (fi) 1985-08-05
FI88400B (fi) 1993-01-29
DK356085A (da) 1986-02-07
DK356085D0 (da) 1985-08-05
JPH0643410B2 (ja) 1994-06-08
EP0486478A2 (en) 1992-05-20
EP0486478A3 (en) 1992-08-12
JPH05194462A (ja) 1993-08-03

Similar Documents

Publication Publication Date Title
FI853004A0 (fi) Nya renin inhiberande polypeptidanaloger och foerfaranden foer framstaellning av dem.
FI854363L (fi) Prefabricerade moduler och anvaendning av dem i byggnadsindustrin.
FI853443L (fi) Nya anvaendningssystem foer soetningsmedel och foerfarande foer framstaellning av dessa.
FI862575L (fi) Paosar foersedda med en dragkedja och foerfarande och anordning foer manuellt fyllning och separering av dem.
FI852188L (fi) Dietfiberprodukter och foerfarande foer framstaellning av desamma.
FI881707A7 (fi) Nya 2 -morfolinoandrostanderivat och metoder foer framstaellning av dem.
FI850998L (fi) Foerfarande och system foer standardisering av ytviktsmaetare.
FI855201L (fi) Belagda fiskfoderpelletter och foerfarande foer framstaellning av dem.
FI851547L (fi) Nagellackkompositioner och anordning foer applicering av dem.
FI860948A0 (fi) Metallmodifierade fenolhartser och foerfaranden foer framstaellning av dem.
FI851059L (fi) Foerfarande och anordning foer styrning av valstryck.
FI861725L (fi) Foerfarande foer framstaellning av betongblandningar och tillsats foer dem i vaetskeform.
FI853491L (fi) Foerfarande och virvelstroemtestsond foer undersoekning av skruvar.
FI852316A0 (fi) Foerfarande och anordning foer kontinuerlig pyrometallurgisk behandling av kopparblysten.
FI851208L (fi) Anordning foer uppbaerning av isolering och fasadputs.
FI850302L (fi) Hydantoinderivat och foerfarande foer producering av dessa.
FI854371L (fi) Foerfarande och anordning foer foerberedande och renande av en blodbehandlingsanordning.
FI862572L (fi) Vasopressinantagonister och foerfarande foer framstaellning av dem.
FI853417A0 (fi) Foerfarande och anordning foer vaermebehandling av staolstaenger.
FI850578A0 (fi) Nagellackkompositioner och foerfarande foer framstaellning av dessa.
FI854276A7 (fi) Foerfarande och anordning foer framstaellning av ostmassablock foer ostberedning.
FI853922L (fi) Foerfarande foer tvaerbindning av en kopolymer av etylen och hydroxialkylester.
FI854108A0 (fi) Anordning foer lyftning och hantering av styckegods.
FI912228A0 (fi) Nya renin inhiberande polypeptidanaloger och foerfaranden foer framstaellning av dem.
FI850767A0 (fi) Foerfarande och anordning foer staengning av en ventilsaeck.

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: THE UPJOHN COMPANY